Under the terms of the agreement, Novartis remains the holder of the registration of these medicines and will be responsible to manufacture them, Glenmark will be responsible for promoting, commercializing and distributing of these products in Brazil.Glenmark enters pact with Novartis to distribute respiratory drugs in Brazil
Under the terms of the agreement, Novartis remains the holder of the registration of these medicines and will be responsible to manufacture them, Glenmark will be responsible for promoting, commercializing and distributing of these products in Brazil.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment